The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/foc.4.4.465

The majority of patients suffering from chronic pain have comorbid mood or anxiety disorders. This is not surprising as there is an affective component to all pain, and the chronic stress and social disruption caused by unrelenting pain erodes the individual’s ability to maintain a sense of identity, social context, and physical and emotional stability. Conversely, patients with chronic affective disorders develop an alarmingly high incidence of chronic pain. Regardless of primacy, when each disorder is present, both should be identified and treated. Anatomical, neurochemical, and neurophysiological commonalities between chronic pain and chronic affective disorders lead to striking overlap of medication treatments used with each group of disorders. Moreover, in treating both types of disorders, sophisticated polypharmacology is often the rule not the exception. With so much biopsychosocial complexity and overlap in mechanisms and treatments, the well-trained psychiatrist is ideally positioned to provide care for patients with chronic pain disorders.